CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Sunflower Pharmaceutical Group Co Ltd Company Snapshot
Sunflower Pharmaceutical Group Co Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sunflower Pharmaceutical Group Co Ltd with three other companies in this sector in China: Guizhou Yibai Pharmaceutical Co., Ltd. (2017 sales of 3.81 billion Chinese Renmimbi [US$549.60 million] of which 81% was Medical Industry), Renhe Pharmacy Company Limited (3.84 billion Chinese Renmimbi [US$554.73 million] of which 98% was Medicine), and Jiuzhitang Company Limited (3.84 billion Chinese Renmimbi [US$553.77 million] of which 102% was Pharmacuetical Industry).

Sales Analysis. Sunflower Pharmaceutical Group Co Ltd reported sales of 3.85 billion Chinese Renmimbi (US$556.40 million) for the year ending December of 2017. This represents an increase of 14.7% versus 2016, when the company's sales were 3.36 billion Chinese Renmimbi. Sales at Sunflower Pharmaceutical Group Co Ltd have increased during each of the previous five years (and since 2012, sales have increased a total of 118%). Sales of Other saw an increase that was more than double the company's growth rate: sales were up 39.0% in 2017, from 74.04 million Chinese Renmimbi to 102.92 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Sunflower Pharmaceutical Group Co Ltd
  Stock Performance Chart for Sunflower Pharmaceutical Group Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (10/19/2018): 16.03
(Figures in Chinese Renmimbi)
1 Week -2.4%   13 Weeks -6.4%  
4 Weeks -31.6%   52 Weeks -7.8%  
 
Sunflower Pharmaceutical Group Co Ltd Key Data:
  Ticker: 002737 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 3,854,759,619
(Year Ending Jan 2018).
Employees: 5,801
  Currency: Chinese Renmimbi Market Cap: 9,361,520,000
  Fiscal Yr Ends: December Shares Outstanding: 584,000,000
  Share Type: A Gu Closely Held Shares: 367,528,668
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.